BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2858708)

  • 1. Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double-blind placebo-controlled randomised study.
    Malaise MG; Hauwaert C; Franchimont P; Danneskiold-Samsoe B; Bach-Andersen R; Gross D; Gerber H; Gerschpacher H; Stocker H; Bolla K
    Lancet; 1985 Apr; 1(8433):832-6. PubMed ID: 2858708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
    Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():87-93. PubMed ID: 3898298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis.
    Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
    Int J Clin Pharmacol Res; 1984; 4(6):451-7. PubMed ID: 6398314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
    Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
    Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopentin (TP-5) in the treatment of rheumatoid arthritis.
    Kantharia BK; Goulding NJ; Hall ND; Davies J; Maddison PJ; Bacon PA; Farr M; Wojtulewski JA; Englehart KM; Liyanage SP
    Br J Rheumatol; 1989 Apr; 28(2):118-23. PubMed ID: 2650797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
    Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
    J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
    Molin L; Schmid F; Bolla K
    Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis.
    Veys EM; Huskisson EC; Rosenthal M; Vischer TL; Mielants H; Thrower PA; Scott J; Ott H; Scheijgrond H; Symoens J
    Ann Rheum Dis; 1982 Oct; 41(5):441-3. PubMed ID: 6751241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
    Franchimont P; Hauwaert C; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study.
    Bolla K; Djawari D; Kokoschka EM; Petres J; Lidén S; Gonseth R; Amblard P; Bernengo MG; Bonerandi JJ; Claudy A
    Surv Immunol Res; 1985; 4 Suppl 1():37-47. PubMed ID: 3898291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some observations on various dose regimens of thymopentin treatment in rheumatoid arthritis.
    Molin L; Schmid F; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():76-80. PubMed ID: 3898296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymopentin therapy reduces the clinical severity of atopic dermatitis.
    Leung DY; Hirsch RL; Schneider L; Moody C; Takaoka R; Li SH; Meyerson LA; Mariam SG; Goldstein G; Hanifin JM
    J Allergy Clin Immunol; 1990 May; 85(5):927-33. PubMed ID: 2185294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymopentin in the treatment of alopecia areata.
    Orecchia G
    Dermatologica; 1989; 178(4):231. PubMed ID: 2670621
    [No Abstract]   [Full Text] [Related]  

  • 14. Thymopentin in the treatment of juvenile chronic arthritis.
    Bardare M; Corona F; Ogliari MT; Cohen E
    Clin Exp Rheumatol; 1990; 8(1):89-93. PubMed ID: 1971780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for thymopentin as therapeutic agent in rheumatoid arthritis.
    Franchimont P; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():70-5. PubMed ID: 3898295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with thymopentin in the treatment of periarthritis humeroscapularis, tendinitis, and gonarthrosis by local infiltration.
    Pipino F; Vittore D
    Arzneimittelforschung; 1988 Jan; 38(1):116-9. PubMed ID: 3284530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of juvenile rheumatoid arthritis treated with thymopentin].
    Tucciarone L; Felici W; Greco L; Mechelli A
    Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients.
    Mascart-Lemone F; Huygen K; Clumeck N; Brenez D; Bolla K; Duchateau J
    Lancet; 1983 Sep; 2(8352):735-6. PubMed ID: 6193382
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective study of thymopentin in severely burned patients.
    Waymack JP; Jenkins M; Warden GD; Solomkin J; Law E; Hummel R; Miller A; Alexander JW
    Surg Gynecol Obstet; 1987 May; 164(5):423-30. PubMed ID: 3554564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results on clinical and immunological effects of thymopentin in AIDS.
    Clumeck N; van de Perre P; Mascart-Lemone F; Cran S; Bolla K; Duchateau J
    Int J Clin Pharmacol Res; 1984; 4(6):459-63. PubMed ID: 6398315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.